<DOC>
	<DOCNO>NCT00980044</DOCNO>
	<brief_summary>Prescription opioid addiction grow public health problem pharmacologic treatment need current approved medication limit patient acceptance ( naltrexone ) , limited availability ( methadone ) , concern misuse diversion ( methadone buprenorphine ) . Tramadol currently approve medication use treat moderate-severe pain , initial study demonstrate may useful treatment uncomfortable syndrome opioid withdrawal without produce euphoric effect . This study determine whether two different dos extend release tramadol treat opioid withdrawal whether tramadol produce withdrawal longer take .</brief_summary>
	<brief_title>Efficacy Extended Release Tramadol Treating Prescription Opioid Withdrawal</brief_title>
	<detailed_description />
	<mesh_term>Substance Withdrawal Syndrome</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<criteria>Addicted opioids Any major medical psychiatric disorder would contraindicate participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>